BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
BioXcel Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
BioXcel Therapeutics reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, three executives at BioXcel Therapeutics received on average a compensation package of $5.6M, a 486% increase compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $9.6M in total, which increased by 386% compared to 2019. 85% of Mehta's compensation, or $8.1M, was in option awards. Mehta also received $556K in non-equity incentive plan, $890K in salary, as well as $7.8K in other compensation.
William P. Kane, Jr, Executive Vice President and Chief Commercial Officer, received a compensation package of $4.6M. 92% of the compensation package, or $4.2M, was in option awards.
Reina Benabou, Senior Vice President and Chief Development Officer, earned $2.7M in 2020.
Related executives
You may also like
Source: SEC filing on April 27, 2021.